Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Kuan Po Peng"'
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-9 (2024)
Abstract Objective Given the findings of central effects of erenumab in the literature, we aimed to conduct a rigorous placebo-controlled, double-blind, randomized study to elucidate whether the observed changes are directly attributable to the drug.
Externí odkaz:
https://doaj.org/article/49a3acc3dca741bf9a45cf38daa2dcc8
Autor:
Mohammad Al-Mahdi Al-Karagholi, Kuan-Po Peng, Anja Sofie Petersen, Irene De Boer, Gisela M. Terwindt, Messoud Ashina
Publikováno v:
The Journal of Headache and Pain, Vol 23, Iss 1, Pp 1-13 (2022)
Abstract Cluster headache and migraine are regarded as distinct primary headaches. While cluster headache and migraine differ in multiple aspects such as gender-related and headache specific features (e.g., attack duration and frequency), both show c
Externí odkaz:
https://doaj.org/article/bd26b8553863444697bac178897750ce
Autor:
Chisato Iba, Seiya Ohtani, Mi Ji Lee, Sunjun Huh, Narumi Watanabe, Jin Nakahara, Kuan-Po Peng, Tsubasa Takizawa
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundMigraine is one of the most common neurological disorders worldwide. Clinical characteristics of migraine may be somewhat different across ethnic groups. Although factors such as stress, lack of sleep, and fasting are known as migraine trig
Externí odkaz:
https://doaj.org/article/99a0faa781d1451a91be826645b21c20
Publikováno v:
Frontiers in Neuroscience, Vol 16 (2022)
The interest in exploring trigeminal pain processing has grown in recent years, mainly due to various pathologies (such as migraine) related to this system. However, research efforts have mainly focused on understanding molecular mechanisms or studyi
Externí odkaz:
https://doaj.org/article/be32cf34934243e88d9e09f892941b89
Publikováno v:
eLife, Vol 11 (2022)
Background: Monoclonal antibodies (mAbs) against calcitonin gene-related peptides (CGRP) are novel treatments for migraine prevention. Based on a previous functional imaging study which investigated the CGRP receptor mAb (erenumab), we hypothesized t
Externí odkaz:
https://doaj.org/article/670164d7de0a412983e78c7b38d2b628
Autor:
Kuan-Po Peng, Thalea Oppermann
Publikováno v:
Cephalalgia Reports, Vol 5 (2022)
Background: Non-dental orofacial pain disorders are not uncommon, but idiopathic or primary facial pain syndromes are rare. Inadequate recognition of these disorders usually leads to unsatisfactory and unmet treatment needs. Methods: We conducted a n
Externí odkaz:
https://doaj.org/article/2ea59b9c8f5f4c91a0845994220bf3ba
Autor:
Kuan-Po Peng1, May, Arne1 a.may@uke.uni-hamburg.de
Publikováno v:
Cephalalgia. Apr2023, Vol. 43 Issue 4, p1-3. 3p.
Publikováno v:
Headache: The Journal of Head and Face Pain. 63:353-359
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31248c61ebd81e275b01adc8d28bb0a6
https://doi.org/10.1111/head.14471
https://doi.org/10.1111/head.14471
Publikováno v:
Cephalalgia Reports, Vol 3 (2020)
Externí odkaz:
https://doaj.org/article/c2d15e70a62b4faab1ff25098e6475f3
Publikováno v:
European Journal of Pain. 26:2152-2161
The exact mechanism and site of action of triptans in aborting migraine attacks remain under debate. We hypothesized that the clinical efficacy of triptans lies in aborting central sensitization and focused on the question of why triptans are headach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebb3460503167b78b4e386805cb91a6c
https://doi.org/10.1002/ejp.2027
https://doi.org/10.1002/ejp.2027